AARDVARK THERAPEUTICS, INC. Debt Securities, Available-for-sale, Amortized Cost
AARDVARK THERAPEUTICS, INC. (AARD) had Debt Securities, Available-for-sale, Amortized Cost of $28.73 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-11
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $28.73M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $62.86M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $86.93M.
- 2025-06-30: Debt Securities, Available-for-sale, Amortized Cost $115.81M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-03-31 | $28.73M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $62.86M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $86.93M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $115.81M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $124.69M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $11.98M 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |